Amanat Files Full Terms of $200M Corxel De-SPAC With $300M PIPE
AMAN is trading near its 52-week low of $9.98 (2.4% above the low).
Summary
Amanat filed the full business combination agreement for its $200 million merger with Corxel Pharmaceuticals, including a $300 million PIPE, a $200 million minimum cash closing condition and break fees of up to $50 million, with Corxel paying Amanat termination fees of $10 million to $50 million.
Updated with an SEC 425 filing · What changed
Updates
· SEC 425 — The deal carries a $200M minimum cash closing condition and $10M-$50M termination fees payable by Corxel to Amanat.
Key Events · M&A and Partnerships · AMAN
-
Updated · · SEC 425
Break Fees Up to $50M Payable by Corxel
To take a superior offer, Corxel pays Amanat the greater of $10,000,000 and 1% of upfront consideration (capped at $50,000,000); a board recommendation change triggers $10,000,000, and a regulatory block triggers reimbursement of up to $3,000,000 of costs. The termination fees of $10,000,000 to $50,000,000 are payable by Corxel to Amanat.
-
Definitive Corxel De-SPAC Signed
A Business Combination Agreement dated October 25, 2026 sets Corxel's implied equity value at $200,000,000, with Amanat redomiciling to Delaware and merging into Corxel through a two-step merger.
-
$300M PIPE and $200M Cash Floor
Subscription agreements cover $300 million of New Corxel common stock and/or pre-funded warrants. Corxel need only close if trust cash after redemptions, plus PIPE proceeds, plus up to $75,000,000 of its own cash reaches at least $200,000,000.
-
Board Seat Tied to Trust Balance
Amanat gets one New Corxel director (intended to be Rakhi Kumar) only if trust cash remaining after all redemptions exceeds $25,000,000.
Analysis · AMAN · Real Estate & Construction
The definitive contract behind this morning's announcement is now public: Amanat will domesticate to Delaware and merge with Corxel Pharmaceuticals at a $200 million implied equity value, backed by $300 million of committed PIPE money. The terms that decide whether the deal closes are now on the table. Corxel can walk unless trust cash after redemptions, plus PIPE proceeds, plus up to $75 million of its own cash totals at least $200 million; Amanat keeps a board seat only if more than $25 million remains in trust after redemptions. Break fees run up to $50 million (1% of a superior offer, floored at $10 million), locking both sides in, and the termination fees of $10 million to $50 million are payable by Corxel to Amanat. For a SPAC trading near its 52-week low, the $200 million minimum cash condition is the number that matters: heavy redemptions would kill the deal rather than dilute it.
How filings like this one have moved
In the 30 days to Oct 26, 2026, 45.6% of the 241 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMAN was trading at $10.22 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $101.8M. The 52-week trading range was $9.98 to $10.79. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.